SXTC Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Valuation Metrics

The current forward P/E ratio for China SXT Pharmaceuticals Inc (SXTC.O) is 0.00, compared to its 5-year average forward P/E of 0.00. For a more detailed relative valuation and DCF analysis to assess China SXT Pharmaceuticals Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

0.00

Current PE

0.00

Overvalued PE

0.00

Undervalued PE

0.00

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

0.00

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

0.00

Undervalued EV/EBITDA

0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A

5Y Average PS

0.00

Current PS

0.00

Overvalued PS

0.00

Undervalued PS

0.00

Financials

Annual

Quarterly

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

SXTC News & Events

Events Timeline

No data

News

8.5

01-09Globenewswire

China SXT Pharmaceuticals Issues 66.67 Million Shares at $0.15 Each

9.5

01-09Benzinga

Tilray Brands Reports Q2 Earnings Beat, Shares Surge 7.3%

7.5

01-09NASDAQ.COM

China SXT Pharmaceuticals Launches AI Initiative, Stock Rises 13.6%

People Also Watch

Frequently Asked Questions

What is China SXT Pharmaceuticals Inc (SXTC) stock price today?

The current price of SXTC is 0.151 USD — it has decreased -87.92 % in the last trading day.

What is China SXT Pharmaceuticals Inc (SXTC)'s business?

China SXT Pharmaceuticals Inc is a holding company mainly engaged in the research, development, manufacture, marketing and sales of Chinese traditional medicine products (TCMP). The Company sells different types of TCMP products, including Advanced TCMP and Regular TCMP. Advanced TCMP comprises of Directly-Oral-TCMP and After-Soaking-Oral TCMP. Regular TCMP is mainly for hospitals and drug stores for the treatment of various diseases or serving as dietary supplements. The Company sells its products under the brand Suxuantang.

What is the price predicton of SXTC Stock?

Wall Street analysts forecast SXTC stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for SXTC is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is China SXT Pharmaceuticals Inc (SXTC)'s revenue for the last quarter?

China SXT Pharmaceuticals Inc revenue for the last quarter amounts to NaN USD, decreased % YoY.

What is China SXT Pharmaceuticals Inc (SXTC)'s earnings per share (EPS) for the last quarter?

China SXT Pharmaceuticals Inc. EPS for the last quarter amounts to USD, decreased % YoY.

What changes have occurred in the market's expectations for China SXT Pharmaceuticals Inc (SXTC)'s fundamentals?

The market is revising No Change the revenue expectations for SXTC for , with the revenue forecasts being adjusted by % over the past three months. During the same period, the stock price has changed by -90.26%.

How many employees does China SXT Pharmaceuticals Inc (SXTC). have?

China SXT Pharmaceuticals Inc (SXTC) has 75 emplpoyees as of January 10 2026.

What is China SXT Pharmaceuticals Inc (SXTC) market cap?

Today SXTC has the market capitalization of 17.52M USD.